Wilmington, DE, United States of America

Michael Xia

This inventor holds 22 USPTO granted patents and 10 published patent applications, plus 6 CIPO patents and 9 EPO patents, primarily in JAK Inhibitor Development. Top assignees: Incyte Corporation, Incyte Holdings Corporation, Pfizer Corporation. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Xia. Retrieved from https://idiyas.com/inventor/michael-xia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 (Patent Applications = 10)

% Patents Active = 86.4

CIPO Patents = 6 (Patent Applications = 9)

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 7.9

ph-index = 6

Forward Citations = 330(Granted Patents)

Location History:

Hockessin, DE (US) (2007 - 2013)
Wilmington, DE (US) (2009 - 2024)

Company Filing History:

Incyte Holdings Corporation

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Areas of Expertise:

JAK Inhibitors

PD-1/PD-L1 Inhibitor

PIM Kinase Inhibitor

PI3K Inhibitor

FGFR Inhibitor

Purinone Derivatives

Chemokine Receptors

Pyrazolyl-Substituted Compounds

Crystalline Forms

Intermediate Compounds

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428426 - Process and intermediates for preparing a JAK1 inhibitor (2025-09-30),

2. 12071439 - Process and intermediates for preparing a JAK inhibitor (2024-08-27),

3. 12043614 - Salts of a Pim kinase inhibitor (2024-07-23),

4. 12024522 - Salts and processes of preparing a PI3K inhibitor (2024-07-02),

5. 11905292 - Process and intermediates for preparing a JAK inhibitor (2024-02-20),

6. 11897889 - Process and intermediates for preparing a JAK1 inhibitor (2024-02-13),

7. 11780836 - Process of preparing a PD-1/PD-L1 inhibitor (2023-10-10),

8. 11505540 - Salts of a Pim kinase inhibitor (2022-11-22),

9. 11472801 - Crystalline forms of a FGFR inhibitor and processes for preparing the same (2022-10-18),

10. 9908888 - Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidines (2018-03-06),

11. 9714233 - Processes and intermediates for making a JAK inhibitor (2017-07-25),

12. 9000161 - Processes for preparing JAK inhibitors and related intermediate compounds (2015-04-07),

13. 8987443 - Processes and intermediates for making a JAK inhibitor (2015-03-24),

14. 8703783 - Purinone derivatives as HM74A agonists (2014-04-22),

15. 8563582 - 3-aminocyclopentanecarboxamides as modulators of chemokine receptors (2013-10-22),

Title: The Inventor Michael Xia: Pioneering Innovations in Wilmington

Introduction: Michael Xia is a distinguished inventor based in Wilmington, DE, known for his groundbreaking contributions to various technological fields.

Latest Patents: Michael Xia holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With over two decades of experience in the innovation industry, Michael Xia has worked for leading tech companies, where he spearheaded the development of revolutionary products that have significantly impacted the market.

Collaborations: Throughout his career, Michael Xia has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and excellence in all his projects. His ability to work in multidisciplinary teams has led to the creation of disruptive technologies.

Conclusion: Michael Xia's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, solidifies his position as a visionary inventor shaping the future of technology.

Profile summary based on public USPTO records.